2025 ICD-10-CM Diagnosis Code Z12.6

Encounter for screening for malignant neoplasm of bladder

  • Z12.6 is a billable/specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes.
  • The 2025 edition of ICD-10-CM Z12.6 became effective on October 1, 2024.
  • This is the American ICD-10-CM version of Z12.6 – other international versions of ICD-10 Z12.6 may differ.

The following code(s) above Z12.6 contain annotation back-references

 that may be applicable to Z12.6:

  • Z00-Z99  Factors influencing health status and contact with health services
  • Z00-Z13  Persons encountering health services for examinations
  • Z12  Encounter for screening for malignant neoplasms

Approximate Synonyms

  • Screening for cancer of urinary bladder done
  • Screening for urinary bladder cancer

Present On Admission

  • Z12.6 is considered exempt from POA reporting.

ICD-10-CM Z12.6 is grouped within Diagnostic Related Group(s) (MS-DRG v42.0):

  • 951 Other factors influencing health status

Convert Z12.6 to ICD-9-CMCode History

  • 2016 (effective 10/1/2015): New code (first year of non-draft ICD-10-CM)
  • 2017 (effective 10/1/2016): No change
  • 2018 (effective 10/1/2017): No change
  • 2019 (effective 10/1/2018): No change
  • 2020 (effective 10/1/2019): No change
  • 2021 (effective 10/1/2020): No change
  • 2022 (effective 10/1/2021): No change
  • 2023 (effective 10/1/2022): No change
  • 2024 (effective 10/1/2023): No change
  • 2025 (effective 10/1/2024): No change

Diagnosis Index entries containing back-references to Z12.6:

  • Screening (for) Z13.9
    • neoplasm (malignant) (of) Z12.9
      • bladder Z12.6
      • genitourinary organs NECZ12.79
        • bladder Z12.6
error: Content is protected !!